Andere Sprachen Stoke Therapeutics, Inc.

Aktien

Markt geschlossen - Nasdaq Andere Börsenplätze 22:30:00 06.05.2024			% 5 Tage	% 1. Jan.
11,87 ^USD	-1,25 %		+0,08 %	+125,67 %

06.05.	Stoke Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
29.04.	Stoke Therapeutics ernennt Thomas Leggett zum CFO	MT

Stoke Therapeutics : Corporate Presentation - May 2024	06.05.
Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M	06.05.
Stoke Therapeutics Reports First Quarter Financial Results and Provides Business Updates	06.05.
Stoke Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06.05.
Stoke Therapeutics Appoints Thomas Leggett CFO	29.04.
Stoke Therapeutics Appoints Thomas Leggett as Chief Financial Officer	29.04.
Stoke Therapeutics, Inc. Announces Executive Changes, Effective May 7, 2024	29.04.
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	17.04.
Stoke Therapeutics Appoints Jason Hoitt as Chief Commercial Officer	17.04.
Stoke Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04.04.
Sector Update: Health Care Stocks Advance Premarket Thursday	28.03.
Stoke Therapeutics Prices Upsized $125 Million Share Offering	28.03.
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering	28.03.
North American Morning Briefing : Stocks Edge -2-	27.03.
Stoke Therapeutics Plans $75 Million Public Offering	26.03.
Stoke Therapeutics Announces Proposed Public Offering	26.03.
Sector Update: Health Care Stocks Advance Late Afternoon	26.03.
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients	26.03.
Top Midday Gainers	26.03.
Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading	26.03.

Keine Ergebnisse zu dieser Suche